Ars Pharmaceuticals Inc (SPRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SPRY | ESPR | RLMD | ||
| Company | Ars Pharmaceuticals Inc | Esperion Theraptc | Relmada Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 7.40 | 3.12 | 7.19 | ||
| High | 7.81 | 3.13 | 7.33 | ||
| Low | 7.03 | 3.12 | 6.77 | ||
| Latest | 7.43 | 3.12 | 6.90 | ||
| Change | -0.51 | unch | -0.52 | ||
| % Change | -6.49% | unch | -7.01% | ||
| Volume | 3,673,500 | 8,135,500 | 1,440,700 | ||
| 20-Day Average Volume | 1,933,060 | 21,263,625 | 1,053,870 | ||
| Previous Close | 7.94 | 3.12 | 7.42 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 8.35 | 2.59 | 7.34 | ||
| 20-Day Raw Stochastic | 15.55% | 95.65% | 10.57% | ||
| 20-Day Relative Strength | 38.84 | 64.24 | 49.28 | ||
| Weighted Alpha | -50.80 | +41.93 | +361.58 | ||
| Today's Opinion | 88% Sell | 24% Buy | 64% Buy | ||
| Previous Opinion | 80% Sell | 16% Buy | 100% Buy | ||
| Last Month's Opinion | 88% Sell | 72% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -15.05% since 05/08/26 | -0.64% since 05/08/26 | -5.74% since 05/08/26 | ||
| Low | 7.03 on 05/15/26 | 3.11 on 05/14/26 | 6.77 on 05/15/26 | ||
| High | 9.06 on 05/11/26 | 3.15 on 05/11/26 | 7.66 on 05/13/26 | ||
| 1-Month | |||||
| %Chg | -7.42% since 04/15/26 | +43.78% since 04/15/26 | -3.90% since 04/15/26 | ||
| Low | 7.03 on 05/15/26 | 1.80 on 04/29/26 | 6.77 on 05/15/26 | ||
| High | 9.57 on 05/06/26 | 3.18 on 05/06/26 | 8.00 on 05/06/26 | ||
| 3-Month | |||||
| %Chg | -16.10% since 02/13/26 | -9.04% since 02/13/26 | +85.48% since 02/13/26 | ||
| Low | 7.03 on 05/15/26 | 1.80 on 04/29/26 | 3.45 on 02/17/26 | ||
| High | 9.65 on 03/10/26 | 3.68 on 02/18/26 | 8.00 on 05/06/26 | ||
| 6-Month | |||||
| %Chg | -9.56% since 11/14/25 | +7.59% since 11/14/25 | +74.68% since 11/14/25 | ||
| Low | 6.66 on 11/21/25 | 1.80 on 04/29/26 | 3.22 on 02/04/26 | ||
| High | 13.15 on 01/12/26 | 4.18 on 01/08/26 | 8.00 on 05/06/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 737,310 | 803,188 | 723,741 | ||
| Shares Outstanding, K | 99,301 | 257,432 | 104,890 | ||
| Annual Sales | 84,280,000 | 403,140,000 | 0 | ||
| Annual Net Income | -171,300,000 | -22,680,000 | -57,390,000 | ||
| Last Quarter Sales | 28,090,000 | 80,100,000 | 0 | ||
| Last Quarter Net Income | -41,320,000 | -25,200,000 | -19,870,000 | ||
| 60-Month Beta | 0.93 | 0.91 | 0.43 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.42 on 03/09/26 | -0.10 on 05/08/26 | -0.22 on 05/12/26 | ||
| Earnings Date | 05/15/26 | 08/04/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||